Poster Session 1
Daniel Gabbai, MD, MPH
Lis Hospital for Women’s Health, Tel Aviv Sourasky Medical Center
Tel-Aviv, Tel Aviv, Israel
Emmanuel Attali, MD
Lis Hospital for Women’s Health, Tel Aviv Sourasky Medical Center
Tel-Aviv, Tel Aviv, Israel
Itamar Gilboa, MD
Lis Hospital for Women’s Health, Tel Aviv Sourasky Medical Center
Tel-Aviv, Tel Aviv, Israel
Yariv Yogev, MD
Lis Maternity Hospital, Sourasky Medical Center, Tel Aviv University
Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Anat Lavie, MD
Tel Aviv Sourasky Medical Center
Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
We conducted a retrospective cohort study at a university-affiliated tertiary medical center with approximately 12,500 deliveries annually (2012-2023). The study included women with P-PROM who planned a trial of labor, excluding those opting for elective CD or with non-viable fetuses. We compared maternal and neonatal characteristics between those who delivered vaginally and those who underwent intrapartum CD. Risk factors were identified using univariate and multivariate logistic regression analyses. A predictive risk score was developed based on the relative risk of each factor, with model performance assessed using the ROC curve.
Results:
1. During the study period, 145,833 women delivered at our center. Of these, 1,494 (1%) were admitted with P-PROM and were eligible for analysis.
2. Among these, 470 (31.5%) underwent intrapartum CD, with a median gestational age of 34.5 weeks (IQR 32.3, 36.0) compared to 35.4 weeks (IQR 33.5, 36.4) in women who delivered vaginally.
3. Multivariate analysis revealed that maternal age > 40 years, multiple gestations, and previous CD are independent risk factors for intrapartum CD. Conversely, BMI > 30, use of oxytocin or antibiotics during labor, and spontaneous onset of labor were protective factors. We assigned risk scores to each factor and incorporated them into our model. [Table 2].
4. The developed risk score model, with a cut-off of 7, predicted intrapartum CD with an area under the curve of 0.85 (95% CI [0.80-0.88], p< 0.001), demonstrating 70% sensitivity and 80% specificity.
Conclusion:
Utilizing our risk score to assess factors before and during labor can aid clinicians in making more informed decisions regarding the risk for intrapartum CS in women with P-PROM.